UK markets closed

Torii Pharmaceutical Co., Ltd. (TRXPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
24.570.00 (0.00%)
At close: 02:13PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 714.60M
Enterprise value 433.64M
Trailing P/E 26.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.87
Price/book (mrq)0.75
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) 0.34
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 324.57
52-week low 324.57
50-day moving average 324.57
200-day moving average 324.57

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 528.11M
Implied shares outstanding 628.47M
Float 89.77M
% held by insiders 155.45%
% held by institutions 121.62%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 439.96%
Dividend date 3N/A
Ex-dividend date 427 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.39%
Operating margin (ttm)10.29%

Management effectiveness

Return on assets (ttm)3.27%
Return on equity (ttm)4.48%

Income statement

Revenue (ttm)56.28B
Revenue per share (ttm)2,002.43
Quarterly revenue growth (yoy)13.90%
Gross profit (ttm)N/A
EBITDA 7.32B
Net income avi to common (ttm)5.29B
Diluted EPS (ttm)0.95
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)40.68B
Total cash per share (mrq)1,447.35
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)6.50
Book value per share (mrq)4,235.51

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A